For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your location into the box below, to view site information related to your location.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Visit protocols and troubleshooting or check them out using the Abcam app for iPhone
Protocols and troubleshooting
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
Whether you're looking to measure PD-L1, PD1 or CTLA-4, browse our range of immuno-oncology ELISA kits and matched antibody pairs.
The PD-1/PD-L1 pathway has shown promising clinical success as a cancer immunotherapy target. Learn how this pathway may lead to the next breakthrough.
Canadian Cancer Immunotherapy Consortium Annual Meeting, September 18-20, 2019 in Toronto, Canada
Watch this on-demand webinar presented by guest speaker Dr George Prendergast, it provides an overview of the future of Immunochemotherapy with a focus on the convergence of cross-disciplinary themes.
Compare our top recombinant PD-L1 antibody clones.
We've added to our range of best-in-class IHC optimized antibodies to bring you access to more highly validated antibodies against immuno-oncology targets.
Learn how current cancer immunotherapies involve immune checkpoint modulators, adoptive T-cell therapy, and vaccines to reverse the growth of cancer tumors
Comprehensive guide to Human CD antigens.
Highly characterized in IHC, Flow Cyt and ICC/IF and knockout (KO) validated.
Find the antibodies and assay kits you need to unlock the power of immuno-oncology. Includes products for PD-L1, PD-1, CTLA4 and CXCR4.